纤维肌痛指南的患者版本 (2025年版)
Zhiling Zhang1,2, Pengxiang Zhou1, Na He1
1Department of Pharmacy, Peking University Third Hospital, Beijing, China.
这项研究创建了一个基于证据的纤维肌痛患者指南,增强患者对症状和治疗方法的理解,以改善自我管理. 该指南实现了100%的可理解性.
科学领域:
- 风湿病学和患者教育
- 准则的制定和传播.
背景情况:
- 纤维肌痛管理需要清晰,以患者为中心的信息.
- 现有的指导方针可能无法完全解决患者的理解或自我管理需求.
研究的目的:
- 开发基于证据的患者版本的纤维肌痛指南 (PVG).
- 改善患者对纤维肌痛症状和治疗选择的理解.
- 为了提高患者的自我管理能力.
主要方法:
- 包括患者代表在内的多学科团队开发了PVG.
- 系统的文献审查和专家的共识为指导方针提供了信息.
- 大型语言模型 (LLM) 与专家审查集成,以提升问题精确度.
- 德尔菲共识和建议的评级评估,开发和评估 (GRADE) 方法用于建议.
- 打印材料的患者教育材料评估工具 (PEMAT-P) 评估了可理解性.
主要成果:
- 最终的PVG解决了7个领域的13个临床问题.
- 建议涵盖疾病意识,诊断,药物和非药物干预以及长期管理.
- 所有的建议都被评为强有力的.
- 该指南强调了药理管理,情绪调节和运动.
- 在PEMAT-P评估中,可理解性得分为100%.
结论:
- 成功开发了一种合作的,基于证据的PVG治疗纤维肌痛.
- 通过LLM集成,提升了问题生成和可读性.
- 该PVG作为早期纤维肌痛自我管理的实用工具.
更多相关视频
11:26Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
Published on: July 14, 2018
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
相关概念视频
Peripheral Artery Disease IV: Nursing Management
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Rheumatic Heart Disease IV: Nursing Management
Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
